Recently some new medicines as anti-TNF bodies and T cell directed agents are used in treatment.
近年来国际上对其治疗的研究已主要集中在分子水平上，如抗肿瘤坏死因子（TNF） 抗体，T细胞靶向药物等。
Other risk factors were age, the first year of anti-TNF mAb treatment, and being born in an endemic area.
其他的危险因素有年龄、抗TNF单抗治疗第一年及出生在结核流行区。
Drugs recommended to be stopped before pregnancy include methotrexate and leflunomide, plus the biologics: anti-TNF agents, rituximab and abatacept.
怀孕前应终止使用的药物包括甲氨蝶呤、来氟米特和一些生物制剂包括抗肿瘤坏死因子制剂、利妥昔单抗和阿巴西普。
The effects of HSS in experimental liver necrosis in rat and the mechanism of its anti-TNF effect in TNF-induced liver necrosis have been studied in this paper .
本文应用实验性肝坏死大白鼠研究人胎肝细胞生长刺激物质（HSS）、抗肿瘤坏死因子（TNF）的作用及其机理。
Conclusion: In situ hepatoma-specific gene therapy with IL-2 and TNF gene mediates anti-hepatoma immune response, but the mechanisms seem different.
结论：IL - 2或TNF肝癌特异性原位基因治疗介导免疫抗肿瘤反应，但机理有所不同。
Conclusion: In situ hepatoma-specific gene therapy with IL-2 and TNF gene mediates anti-hepatoma immune response, but the mechanisms seem different.
结论：IL - 2或TNF肝癌特异性原位基因治疗介导免疫抗肿瘤反应，但机理有所不同。
应用推荐